Purpose. To assess the compression and flexural strength of bone cement mixed with 0 ml, 1 ml, or 2 ml of blood. Methods. High viscosity polymethyl methacrylate (PMMA) loaded with or without gentamicin was used. Blood was collected from total knee arthroplasty patients. In the same operating room, one pack of cement each was mixed with 0 ml (control), 1 ml, or 2 ml of blood for 1 minute during the dough phase. The dough was extruded into cylindrical and rectangular moulds for 20 minutes of setting, and then cured in phosphate buffered saline at 37±1ºC for 7 days. The samples were visually inspected for fractures and areas of weakness, and then scanned using microcomputed tomography. 48 gentamicin-loaded and 59 non-gentamicin-loaded samples mixed with 0 ml (control), 1 ml, or 2 ml of blood were randomised for flexural and compression strength testing; each group had at least 6 samples. Results. In samples loaded with or without
gentamicin, the flexural and compressive strength was highest in controls, followed by samples mixed with 1 ml or 2 ml of blood. In samples mixed with 2 ml of blood, the flexural strength fell below the standard of 50 MPa. In samples mixed with 2 ml of blood and all gentamicin-loaded samples, the compressive strength fell below the standard of 70 MPa. Microcomputed tomography revealed areas of voids and pores indicating the presence of laminations and partitions within. Conclusion. The biomechanical strength of PMMA contaminated with blood may decrease. Precautions such as saline lavage, pack drying the bone, change of gloves, and prompt insertion of the implant should be taken to prevent blood from contaminating bone cement. may demonstrate evidence of aseptic loosening. [1] [2] [3] [4] The hospital cost increases from $24 170 for a primary procedure to $34 341 for a revision procedure, with operating time increased by 41%, estimated blood loss by 160%, complication rate by 32%, and length of stay by 16%. 5 In total hip arthroplasty (THA), advanced cementation techniques (including brushing, saline lavage, cement bone plugging, pack drying, retrograde insertion with a cement gun, pressurisation, and late implant insertion) have improved long-term outcome by reducing the aseptic loosening rate by a factor of almost 10. [6] [7] [8] [9] [10] In total knee arthroplasty (TKA), cementation techniques are not constantly used by surgeons. 11 In a national survey of British orthopaedic surgeons, only 43% used pulsatile lavage and only 88% dried the bone before cementing the implant. 12 16.1% to 41.5% of revision surgeries were due to aseptic loosening, particularly implant failure after >2 years. [13] [14] [15] Polymethyl methacrylate (PMMA) has been used to fix the prosthesis and ensure equal load transference from the prosthesis to the bone. 16, 17 Aseptic loosening of the knee implant is associated with the depth and amount of cement used. [18] [19] [20] [21] Contaminants such as bone marrow, interfacial blood, saline, and other bodily fluids can cause de-bonding, micro-motion, and loosening at the implant-cement interface. [22] [23] [24] This study assessed the compression and flexural strength of PMMA mixed with 0 ml, 1 ml, or 2 ml of blood.
Materials and Methods
This study was approved by the institutional review board of our hospitals. A pilot study showed that the standard amount of cement used in a TKA was 20 g, and cement could be contaminated by 0.5 to 1 ml of blood. High viscosity bone cement loaded with or without gentamicin (SmartSet; DePuy CMW, Blackpool, UK) was used. Blood was collected from TKA patients. In the same operating room, one pack of cement each was mixed with 0 ml (control), 1 ml, or 2 ml of blood for 1 minute during the dough phase. The dough was extruded into cylindrical (12±1 mm in length and 6±1 mm in diameter) and rectangular (44±1 mm long, 10±1 mm wide, and 6±1 mm thick) stainless steel moulds for 20 minutes of setting. The samples were visually inspected for surface defects. Acceptable samples were polished with sandpaper and cured in phosphate buffered saline at 37±1ºC for 7 days. The samples were visually inspected for fractures and areas of weakness, and then scanned using micro-computed tomography.
48 gentamicin-loaded and 59 non-gentamicinloaded samples mixed with 0 ml (control), 1 ml, or 2 ml of blood were randomised for flexural and compression strength testing; each group had at least 6 samples.
For flexural strength testing (of the rectangular samples), the Instron-5543 Universal Testing Machine was used, with the crosshead speed set at 10 mm/ minute. The flexural strength was calculated using the formula: B=3Fa/bh2, where F was the force at break in N, b was the mean width in mm, h was the mean thickness in mm, and a was the span length fixed at 20 mm.
For compression strength testing (of the cylindrical samples), the MTS 858 Bionix Universal Testing Machine was used, with the crosshead speed set at 25 mm/minute, and the failure load set at 40% or at fracture point. Compressive strength was calculated as failure load divided by cross-sectional area.
Independent t-test was used to compare the pairwise difference between samples mixed with 0 ml (control), 1 ml, or 2 ml of blood in terms of flexural and compressive strength. A p value of <0.05 was considered statistically significant.
results
In non-gentamicin-loaded samples, the flexural strength was highest in controls (90.1±10.5 MPa), followed by samples mixed with 1 ml of blood (69.6±11.5 MPa, p=0.022) or 2 ml of blood (48.3±3.1 MPa, p<0.0001); the difference between the latter 2 was also significant (p=0.024) [Table] . In gentamicinloaded samples, the flexural strength was highest in controls (68.4±11.5 MPa), followed by samples mixed with 1 ml of blood (60.1±8.7 MPa, p=0.700) or 2 ml of blood (40.9±4.3 MPa, p=0.001); the difference between the latter 2 was also significant (p=0.018) [Table] . In samples mixed with 2 ml of blood, the flexural strength fell below the standard of 50 MPa.
In non-gentamicin-loaded samples, the compressive strength was highest in controls (87.5±4.2 MPa), followed by samples with 1 ml of blood (73.9±5.1 MPa, p<0.0001) or 2 ml of blood (67.4±3.7 MPa, p<0.0001); the difference between the latter 2 was not significant (p=0.094). In gentamicin-loaded samples, the compressive strength was highest in controls (61.2±1.7 [Table] MPa), followed by samples mixed with 1 ml of blood (60.1±6.2 MPa, p=0.998) or 2 ml of blood (53.0±4.7 MPa, p=0.008); the difference between the latter 2 was also significant (p=0.016)
[ Table] . In samples mixed with 2 ml of blood and all gentamicin-loaded samples, the compressive strength fell below the standard of 70 MPa.
In samples mixed with blood, micro-computed tomography revealed areas of voids and pores indicating the presence of laminations and partitions within (Fig. 1) .
discussion
A blood lamination in the bone-cement-implant interface may be a mode of aseptic loosening. 22, 25 A reduction in shear and tensile strength may lead to aseptic loosening. 11, 24, 26, 27 When PMMA cement is contaminated with blood, micro-morphological changes to gap and void formation in the surface structure may develop, and shear strength is markedly reduced. 22 In our study, after flexural and compressive strength testing, fractures within the cement mantle consistently occurred in areas of weakness caused by blood laminations, which were not noted before curing and were more prominent after curing to the extent of disrupting the previously smooth cylindrical contour of the specimen (Fig.  2) . The lamination was absent in controls that were compressed uniformly without oblique or spiral fractures of the cement mantle (Fig. 2) . Large radiolucent voids were noted in samples mixed with blood, especially in the gentamicin-loaded samples.
Failure of the cement mantle may be a mechanism of failure. 11, 24, 26, 27 In all our gentamicin-loaded samples, the compressive strength was below the ISO 5833 and ASTM F451 standard of 70 MPa; this is consistent with samples in one study after curing and elution. 28 Nonetheless, another study reported compressive strength of 86 MPa in 7 commercially available gentamicin-loaded cements that were not cured, 17 whereas our samples were cured in phosphatebuffered saline at 37±1°C for 7 days. Because of the elution properties of antibiotic-loaded cements, its biomechanical properties can significantly reduce after curing. 29, 30 In a surgical setting, antibiotic-loaded cement contaminated with blood may affect the integrity of the cement mantle and reduce flexural and compressive strength below accepted levels. This may result in fracture of the cement mantle and aseptic loosening of the implant.
There were limitations to our study. Our findings could not be extrapolated to all PMMA cements, as different cement preparations may result in different mechanical properties. Larger studies with a wider range of commercially available cements to investigate more cement properties such as fatigue strength and release kinetics of the blood and antibiotics are needed. Blood contamination of PMMA may decrease its biomechanical strength, but it is unreasonable to conclude that blood contamination of PMMA increases the risk of aseptic loosening. Nonetheless, cement fracture is widely regarded as a major factor in the mechanical failure of the cement mantle, which plays a role in aseptic loosening of the implant. 16 conclusion The biomechanical strength of PMMA contaminated with blood may decrease. Precautions such as saline lavage, pack drying the bone, change of gloves, and prompt insertion of the implant should be taken to prevent blood from contaminating bone cement.
disclosure
No conflicts of interest were declared by the authors.
